Since a corresponding increase in gene expression level is associated with elevation in amount and intensity of the cytotoxic drug, we reasoned that both PLEKHA8P1 and PLEKHA8 confer 5-FU resistance in HCC cells. The gene discussed is PLEKHA8; the disease is hepatocellular carcinoma.